Bringing Health-Related
Technologies closer to the Filipino and Beyond
The company prides itself to have a team of highly trained, dedicated, multi awarded roster of scientists-entrepreneurs, infectious disease experts, molecular pathologists, epidemiologist,
molecular biologists, microbiologists and regulatory experts that believes in the role of science and technology research in nation building.
October 14, 2024
Two years ago, Manila HealthTek Inc. made significant strides in addressing the African Swine Fever (ASF) epidemic that severely impacted the swine industry in the Philippines. With an unwavering commitment to controlling this health crisis, the company developed an innovative, FDA-approved ASF detection kit. This breakthrough is a clear testament to the dedication and capability of Filipino scientists in supporting local agriculture.
The success of this venture owes much to the vibrant local biotechnology ecosystem. This ecosystem not only bolsters the growth of the science and technology sector in the Philippines but also empowers local biotechnological initiatives that play crucial roles in the nation's development.
Manila HealthTek Inc. extends heartfelt gratitude to all local stakeholders and users who have placed their trust in Filipino expertise. Their support and confidence fuel the company's passion for innovation, driving its commitment to making meaningful contributions to the community.
In unison, we are creating pathways for a healthier and more prosperous future. As always, Manila HealthTek Inc. remains committed to serving the nation with heartfelt dedication.
Kabayan, andito lang po kami, taus-pusong handang tumulong. #ParaSaBayan
October 14, 2024
In a monumental stride towards scientific advancement, the S.A.N.I.B Consortium (Strategic Alliance for Novel Innovations in Biotechnology) emerges as a leading force for change and development. This innovative coalition, formed between Manila HealthTek Inc., the University of the Philippines, and Ateneo de Manila University, is further strengthened by remarkable collaborations with the Research Institute for Tropical Medicine and the University of California San Francisco. It symbolizes the tremendous potential of uniting industry expertise, governmental backing, and scholastic brilliance. With a focus on state-of-the-art molecular biology, cutting-edge microfabrication technology, and pioneering nanoparticle-based nucleic acid manipulation, the S.A.N.I.B Consortium aims to transform diagnostic solutions for both communicable and non-communicable diseases. This partnership is more than a mere amalgamation of skills; it represents a fusion of visions geared toward tackling some of today's most critical healthcare issues. Such industry-academic collaborations are indispensable for fostering a robust biotechnology ecosystem in the Philippines. They catalyze the translation of groundbreaking research into practical medical innovations, ensuring that scientific breakthroughs have a profound societal impact. By pooling resources, harmonizing synergies, and maintaining a steadfast commitment to excellence, the S.A.N.I.B Consortium epitomizes how cooperative initiatives can lay the groundwork for a healthier and more inventive future. Collectively, the consortium is not only advancing knowledge but also creating a legacy of creativity and aspiration that will ignite inspiration for future generations. Positioned with abundant intellectual resources and an entrepreneurial zeal, the Philippines is poised to ascend as a global biotechnology leader, thanks to visionary coalitions like the S.A.N.I.B Consortium. Support for such alliances is crucial, as they represent the foundation of progress and hold the keys to unlocking a brighter, more promising tomorrow.
August 27, 2024
In a significant achievement for the field of biomedical research, Dr. Raul V. Destura, a distinguished scientist at the National Institutes of Health, UP Manila, has been awarded the prestigious 2024 Alberto G. Romualdez Jr. Outstanding Health Research Award (AROHRA). This accolade recognizes his pioneering work in the realm of infectious disease diagnostics, specifically his remarkable contributions to the fight against dengue fever.
The award ceremony took place on August 16, 2024, during the 17th Philippine National Health Research System (PNHRS) celebration held in Butuan City. It served as a platform to honor Dr. Destura’s groundbreaking development - the Biotek-M™ Dengue Aqua Kit. This innovative, locally-produced, and cost-effective diagnostic tool has revolutionized the early detection of dengue fever, a disease that poses a significant public health challenge in tropical regions.
Dr. Destura's journey to this achievement is one marked by dedication and innovation. As the founder and CEO of Manila HealthTek Inc., he has consistently exemplified entrepreneurial spirit and scientific rigor. Under his leadership, the company has become a beacon of health innovation, addressing urgent healthcare needs with locally-sourced solutions. His expertise in molecular diagnostics has been a driving force behind many cutting-edge developments in the field.
His work with the Biotek-M™ Dengue Aqua Kit stands as a testament to his commitment to improving health outcomes through accessible technology. This tool not only reduces the cost of dengue diagnosis but also ensures timely and accurate detection, thus playing a crucial role in controlling outbreaks and saving lives. The kit aligns with global goals, including Sustainable Development Goals 3, 9, and 17, focusing on good health, innovation, and partnerships.
The recognition bestowed by the AROHRA is a fitting acknowledgment of Dr. Destura's contributions. His efforts highlight the importance of integrating scientific research with practical applications to meet pressing health challenges. Through Manila HealthTek Inc., Dr. Destura continues to pave the way for future innovations, demonstrating the power of scientific collaboration and ingenuity in solving global health issues.
Dr. Destura's achievements resonate not only within the scientific community but also serve as inspiration to emerging researchers and entrepreneurs in the Philippines and beyond. His work stands as an example of how local scientific talent can contribute significantly to global health solutions.
For more insights into Dr. Destura’s award-winning work and contributions to health science, the link can be found in the comment section.
Stay informed about breakthrough health innovations by following #UniversityofthePhilippines, #UP, #UPManila, and #HealthInnovation. Join the conversation with #BiotekM, #DengueDetection, #AROHRA2024, #DrRaulDestura, along with SDGs #SDG3, #SDG9, and #SDG17.
May 15 2018
BIOTEK-MTM Dengue Aqua Kit , a Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) assisted technology, was one of the gold awardees during the 46th International Exhibition of Inventions Geneva held on 11-15 April 2018 at Palexpo, Geneva.
January 19 2016
Dr. Raul V. Destura, an internal medicine and infectious disease specialist from the National Institutes of Health-University of the Philippines Manila, was named recently by the National Research Council of the Philippines (NRCP) as the 2015 Dr. Eusebio Y. Garcia Awardee during its 82nd Founding Anniversary Celebration at the Bayleaf, Intramuros, Manila.
July 2016
A microbiologist who developed a portable kit that can detect within an hour the presence of dengue virus in the blood and a University of the Philippines (UP) professor who used computer programs to develop designer drugs against tuberculosis were among the winners of this year’s National Science and Technology Week (NSTW) Awards.
Feb 9 2021
The country’s first and only biotech company in diagnostics, Manila HealthTek Inc. (MTek) added another feather to its cap. It recently won its second Gawad Dagisik (Dakilang Ambag sa Imbensyon at Siyensiyang Pangkalusugan) award for its “Alay Sa bayan: The Story of Manila HealthTek Inc.’s Biotek-M Trio Kit.”
Oct 27 2021
Secured the approval of the Food and Drug Administration (FDA) on Oct. 12 for its test kit that detects African Swine Fever (ASF).
March 29 2022
Dr. Raul V. Destura, a microbiologist and infectious disease expert, director of the Institute of Molecular Biology and Biotechnology, and deputy executive director of the Philippine Genome Center.
